GADGVGKSA
Cat.No:CLP1738 Solarbio
CAS:2032119-68-7
Molecular Formula:C30H52N10O13
Molecular Weight:760.79
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:2032119-68-7
Molecular Formula:C30H52N10O13
Molecular Weight:760.79
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 2032119-68-7 |
Sequence(1LC) | GADGVGKSA |
Sequence(3LC) | Gly-Ala-Asp-Gly-Val-Gly-Lys-Ser-Ala |
Molecular Formula | C30H52N10O13 |
Molecular Weight | 760.79 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Other Peptides |
Background | GADGVGKSA is a mutant KRAS G12D 9mer peptide. GADGVGKSA can be used as an immunogenic neoantigen for cancer immunotherapy research. |
Reference | [1]. Bai P, et al. Characters of neoantigens in cancer immunotherapy. bioRxiv, 2019: 700732. |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.